Regeneron Pharmaceuticals Inc PE Ratio
Data as of August 04, 2026
PE Ratio (TTM)
17.67
Stock Price
$759.24
EPS (TTM)
$41.03
Forward PE
14.12
How It's Calculated
17.67 = $759.24 ÷ $41.03
What This Means
Regeneron Pharmaceuticals Inc's PE ratio of 17.7 is in the moderate range, typical of established companies with steady earnings growth.
About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals Inc (REGN) operates in the Biotechnology sector, specifically in Biotechnology. With a market capitalization of about $79.94B, it ranks as a large-cap stock — a major established company.
Shares recently traded near $759.24, within a 52-week range of $541.00 to $821.11 (-7.5% from the high, +40.3% from the low). Beta of 0.19 indicates relatively lower volatility versus the market.
Trailing profit margin is about 29.6%, signaling a strong profit margin relative to many peers.
Understanding This Metric
The PE ratio is one of the most widely cited valuation multiples. For Regeneron Pharmaceuticals Inc, it reflects how much investors pay today for each dollar of trailing earnings. High-growth Biotechnology names often carry elevated PE ratios when the market prices in faster future profits, while mature companies with stable cash flows may trade at lower multiples even in the same sector.
Sector Comparison
Among Biotechnology names on our S&P 100 coverage, Regeneron Pharmaceuticals Inc's PE ratio of 17.67 can be compared with peers such as AMGN (26.22), GILD (17.54). Sector context helps interpretation, but each company's growth profile and balance sheet differ — use multiple metrics before drawing conclusions. View all Biotechnology stocks.
Key Takeaways
- REGN is grouped in the Biotechnology sector for peer comparisons.
- Recent beta of 0.19 suggests lower-than-market price sensitivity.
- Trailing profit margin of 29.6% provides context for how much earnings support the headline multiple.
Related Tools & Guides
Explore calculators and guides connected to this metric, or view all metrics for REGN.
Learn the full workflow
Compare PE with PB, PEG, EV/EBITDA, and market cap in one structured path.
Open the Stock Valuation hub →PEG Ratio
0.86
Sector
Biotechnology
Other REGN Metrics
Frequently Asked Questions
What does REGN's PE ratio mean?
The PE ratio shows how much investors pay per dollar of trailing earnings for Regeneron Pharmaceuticals Inc. A trailing PE of 17.67 means the market is pricing the stock at 17.67 times last twelve months' EPS — useful for comparing valuation across time and versus Biotechnology peers, not as a buy/sell signal on its own.
Is 17.67 high or low vs sector peers?
Among Biotechnology names in our S&P 100 coverage, peers such as GILD (17.54), AMGN (26.22) offer context. REGN's PE of 17.67 should be read with growth, margins, and balance-sheet risk — high PE can mean strong growth expectations; low PE can mean value or weaker outlook.
How often is this PE updated?
StockCalc refreshes REGN metrics on U.S. trading days; this page shows data as of August 04, 2026. PE moves with price daily and with EPS when companies report earnings.
Calculate the pe ratio for any stock with our free calculator.
Open PE Ratio Calculator →